Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03694678 · ClinicalTrials.gov registry record · NA

Building Resiliency in Patients Admitted to the Neuroscience Intensive Care Unit and Their Caregivers

A NA study, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
126
Enrollment target

NCT03694678: Completed NA study, sponsored by Massachusetts General Hospital.

NCT03694678 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 126 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03694678, a NA study, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
126 participants
Enrollment target

Study Summary

The investigators will compare a dyadic intervention (Recovering Together) with an attention placebo educational control in dyads of patients with acute neurological illnesses and their caregivers at risk for chronic emotional distress. The primary aim of this study is to determine the feasibility, credibility, and satisfaction with Recovering Together. The second aim is to show proof of concept for sustained improvement in emotional distress, post traumatic stress (PTS), resiliency and interpersonal communication outcomes in patients and caregivers.

Primary Outcome

Feasibility of recruitment will be determined by reporting number of dyads who meet study criteria who enrolled

Interventions

  • BEHAVIORAL Recovering Together

Trial Details

FieldValue
Enrollment Target 126 participants
Start Date 2019-01-01
Est. Completion 2020-10-11
Phase NA
Massachusetts General Hospital

2,032 total trials

What the finished NCT03694678 record still lists

NCT03694678 is an interventional study that assigns participants to a tested intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).

The record links to 0 conditions, and to 1 intervention - of which Recovering Together is the first listed.

NCT03694678 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03694678 about?

NCT03694678 is a clinical study titled "Building Resiliency in Patients Admitted to the Neuroscience Intensive Care Unit and Their Caregivers". The investigators will compare a dyadic intervention (Recovering Together) with an attention placebo educational control in dyads of patients with acute neurological illnesses and their caregivers at risk for chronic emotional distress. The primary aim of this study is to determine the feasibility, ...

What is the current status of trial NCT03694678?

This trial is currently completed. It is a NA study. The enrollment target is 126 participants. The study started on 2019-01-01. Estimated completion is 2020-10-11.

What interventions are being tested in trial NCT03694678?

The interventions under investigation include: Recovering Together (BEHAVIORAL).

Who is sponsoring clinical trial NCT03694678?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03694678's enrollment target sits among peer trials

126 749th of 2000 higher than 1,248 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01873131 · 126 participants · NA

    A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn

  • NCT02621645 · 126 participants · Phase 4

    TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence

  • NCT03838107 · 126 participants

    Markers of Trajectory in Pediatric CRPS

  • NCT03906422 · 126 participants · NA

    Comparison of Patient-reported Pain After Initial Archwire Placement

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03694678, the US trial registry maintained by the National Library of Medicine. NCT03694678 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.